WELLESLEY, Mass., Oct. 25, 2017 (GLOBE NEWSWIRE) -- The rise in global consumption of meat and milk, along with the need for increased profitability in animal production, are driving growth in the global market for direct-fed microbials (DFM). BCC Research projects the DFM global market to reach nearly $1.3 billion in 2022, up from $851 million in 2017, demonstrating an 8.1% CAGR.
According to Direct-fed Microbials (DFM): Global Markets to 2022, the rising demand for meat and milk due to the expanding global population is driving an increased use of growth promoters intended to increase milk and meat production. However, many countries have banned the use of antibiotics in animal production in favor of probiotic microbial strains that can also enhance milk and meat production in animals such as cattle and swine. Research has demonstrated that the beneficial microbes such as lactobacillus and bifidobacteria strains can enhance meat and milk production. Thus, the rise in the milk and meat consumption will help increase the use of probiotics in animal production. In turn, this will boost market growth.
Probiotic organisms help to enhance nutrient absorption by breaking down complex compounds, which in turn reduces the cost of animal production and increases the profitability of the animal producers. The varying regulations and increasing cost of production can hinder the market growth. Due to lack of proper definition, the regulations and guidelines vary with different countries and there is an absence of international standards to follow in the production of these products. These factors restrain the use of direct-fed microbial products and reduce the adoption rate. A ban on the use of antibiotic growth promoters and rise in animal health concerns are some of the major factors that can promote growth opportunities and open new avenues for market growth.
Research Highlights
- The U.S. Food and Drug Administration (FDA) and the Association of American Feed Control Officers (AAFCO) have approved at least 42 microbial species for use in direct-fed microbials.
- Dry form, which dominated the market with 2016 revenues of $484 million, is anticipated to reach $792 million by 2022.
- North America, whose 2016 market value of $274 million led all regions, is expected to grow at a 7.4% CAGR through 2022.
“China is one of the direct-fed microbials (DFM) markets experiencing exceptional growth,” said Kevin Fitzgerald, BCC Research editorial director. “Initiatives to ban the use of antibiotics in livestock in this country has encouraged growth; furthermore, many of the markets throughout Asia-Pacific region remain untapped.”
Editors and reporters who wish to speak with the analyst should contact Steven Cumming at steven.cumming@bccresearch.com.
About BCC Research
BCC Research is a publisher of market research reports that provide organizations with intelligence to drive smart business decisions. By partnering with industry experts worldwide, BCC Research provides unbiased measurements and assessments of global markets covering major industrial and technology sectors, including emerging markets. For more information about BCC Research, please visit bccresearch.com. Follow BCC Research on Twitter at @BCCResearch.